Back
Innate Pharma SA Vs. Celanese Industry Stock Comparison
Sell
40
IPHA
Innate Pharma SA
Last Price:
$2.08
Seasonality Move:
-9.96%
Buy
53
CE
Celanese
Last Price:
$52.48
Seasonality Move:
-0.84%
Sell
40
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
-
The current Innate Pharma SA [IPHA] share price is $2.08. The Score for IPHA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
IPHA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.08The current trend is moderately bearish and IPHA is experiencing selling pressure, which indicates risk of future bearish movement.
CE Stock Price Chart
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 47.62 | Sell |
Chaikin Money Flow: | -16852 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.91 - 2.27) | Sell |
Bollinger Bands (100): | (1.81 - 2.17) | Buy |
CE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.5 | Buy |
Relative Strength Index (14 RSI): | 60.57 | Buy |
Chaikin Money Flow: | -808819 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.45 - 49.67) | Buy |
Bollinger Bands (100): | (46.49 - 68.63) | Sell |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.27 | Sell |
20-day SMA: | 2.15 | Sell |
50-day SMA: | 2.02 | Buy |
200-day SMA: | 2 | Buy |
8-day EMA: | 2.21 | Sell |
20-day EMA: | 2.16 | Sell |
50-day EMA: | 2.06 | Buy |
200-day EMA: | 2.07 | Buy |
CE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.71 | Buy |
20-day SMA: | 45.86 | Buy |
50-day SMA: | 49.34 | Buy |
200-day SMA: | 85.41 | Sell |
8-day EMA: | 50.9 | Buy |
20-day EMA: | 48.2 | Buy |
50-day EMA: | 50.37 | Buy |
200-day EMA: | 79 | Sell |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Celanese Earnings Growth & CE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.04 per share, an increase next quarter of $0.11 per share, a decrease this year of $3.05 per share, and an increase next year of $1.67 per share.
Innate Pharma SA Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Celanese Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |